Infectious Disease Diagnostics Market worth $31.5 billion by 2028 | MarketsandMarkets

March 06 15:49 2025
Infectious Disease Diagnostics Market worth $31.5 billion by 2028 | MarketsandMarkets
North America is well-established, with the US being a major market in this region. This dominance can be attributed to various factors, including advanced healthcare infrastructure, a high prevalence of infectious diseases, and significant investments in diagnostic technologies.
Diseases such as tuberculosis, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and timely diagnosis for effective treatment and control. Early diagnosis of these diseases plays a crucial role in the monitoring of these infectious diseases, driving the growth of the market in this area.

Infectious Disease Diagnostics Market – Global Forecast to 2028

The Infectious Disease Diagnostics Market is projected to grow from an estimated USD 21.4 billion in 2023 to USD 31.5 billion by 2028, representing a CAGR of 8.0% during the forecast period.

The report covers key segments, including Product & Service (Reagents, Kits), Test Type (Lab, Point-of-Care), Sample Type (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), and Diseases (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Influenza).

Explore 172 market data tables and 53 figures across 309 pages, offering comprehensive insights into this rapidly evolving market.View the detailed table of contents here: https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html

Key Insights from the Report

  • Reagents, Kits & Consumables Lead the Market:In 2022, the reagents, kits, and consumables segment held the largest market share in the product & service category. This dominance is driven by the recurring need for these products compared to instruments, ensuring consistent demand from diagnostic labs and healthcare providers.

  • Blood, Serum & Plasma Samples Dominate Sample Type Segment:Among sample types, blood, serum, and plasma accounted for the largest share in 2022. These sample types offer a rich source of diagnostic biomarkers, including DNA, RNA, proteins, and other indicators, making them invaluable for accurate disease detection and monitoring.

  • North America is the Leading Regional Market:In 2022, North America led the global infectious disease diagnostics market, with the US being the largest contributor. This leadership stems from advanced healthcare infrastructure, high disease prevalence, and substantial investments in diagnostic technologies.

Key Players in the Market

Leading companies operating in this market include:Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche (Switzerland), bioMérieux (France), Siemens Healthineers (Germany), Danaher (US), Hologic (US), Becton, Dickinson and Company (US), Revvity (US), QIAGEN (Netherlands), Seegene (South Korea), Grifols (Spain), DiaSorin (Italy), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), QuidelOrtho Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech (Ireland), Chembio Diagnostics (US), Co-Diagnostics (US), ELITech Group (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences (India), InBios International (US), Vela Diagnostics (Singapore), and Uniogen Oy (Finland).

Don’t miss out on growth opportunities in the Infectious Disease Diagnostics Market. Talk to our analysts for valuable industry insights to drive your business forward.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html